Entering text into the input field will update the search result below

Arcturus Therapeutics appoints Dr. Christine Esau as VP of R&D

  • Arcturus Therapeutics (NASDAQ:ARCT) has appointed Dr. Christine Esau, Senior Director of Translational Research, as Vice President of Research and Development, effective immediately.
  • Dr. Esau prior to joining Arcturus in 2015, was lead biologist at Ionis Pharmaceuticals and Regulus Therapeutics and served as Chief Scientific Officer of AptamiR Therapeutics.
  • Also, Dr. Pad Chivukula is stepping down as Chief Scientific Officer and Chief Operating Officer and will serve as a Scientific Advisor to the Company.

Recommended For You

More Trending News

About ARCT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ARCT--
Arcturus Therapeutics Holdings Inc.